Ameritas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Ameritas Advisory Services's VRTX Position: Q1 2026 in Review
Ameritas Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 34% in Q1 2026, selling an estimated $292K and leaving 1,216 shares worth $543K. The position accounts for 0.02% of the portfolio, ranked #549.
Ameritas Advisory Services first reported a position in VRTX in Q1 2023 and has held it in 7 quarters since. The position peaked at $835K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Ameritas Advisory Services held 1,216 shares of Vertex Pharmaceuticals worth $543K as of Q1 2026.
- Ameritas Advisory Services sold 626 Vertex Pharmaceuticals shares in Q1 2026, an estimated $292K.
- Vertex Pharmaceuticals made up 0.02% of Ameritas Advisory Services's portfolio in Q1 2026, its #549 holding.
- Ameritas Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
- Ameritas Advisory Services's Vertex Pharmaceuticals position peaked at $835K in Q4 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.